Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
63 studies found for:    SIDS
Show Display Options
Download search resultsDownload the search results for:
SIDS (63 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)
Condition: Sudden Infant Death Syndrome
Intervention: Other: Factors Influencing the Racial Disparity in SIDS
2 Completed Study to Evaluate SID 530 Compared to Taxotere
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: SID530, Taxotere
3 Recruiting Reduce African-American Infant Mortality
Condition: Health Behavior
Intervention: Behavioral: Randomized Messaging Trial
4 Unknown  Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?
Condition: Sudden Infant Death
5 Recruiting Changes in Sleep Patterns and Stress in Infants Entering Child Care
Condition: Sudden Infant Death Syndrome
6 Completed Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)
Conditions: Sudden Infant Death Syndrome;   Apnea
7 Recruiting An Open-Label Randomized Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Patients With HER2-Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration
Condition: Breast Cancer
Interventions: Drug: trastuzumab IV;   Drug: trastuzumab SC vial;   Drug: trastuzumab SID
8 Unknown  Measuring Response to Depression Treatment
Condition: Depression
Intervention: Other: Treatment-as-usual
9 Completed Influence of Pacifiers on Breastfeeding Duration
Condition: Sudden Infant Death
Intervention: Behavioral: offer a pacifier
10 Recruiting A Safety and Tolerability Study of Assisted- and Self-Administered Subcutaneous Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With Early HER2-Positive Breast Cancer (SafeHer)
Condition: Breast Cancer
Intervention: Drug: trastuzumab [Herceptin]
11 Completed Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England
Conditions: Stillbirth;   Infant Mortality;   Sudden Infant Death;   Infant, Low Birth Weight;   Infant, Very Low Birth Weight
Intervention: Other: Smoke-free legislation
12 Completed Parental Knowledge and Beliefs About Infant Sleep Position
Condition: Sudden Infant Death Syndrome
Intervention: Behavioral: Parental knowledge and beliefs about infant sleep position
13 Completed Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: BYK324677
14 Completed Magnetic Resonance Imaging Autopsy Study
Conditions: Stillbirths;   Sudden Infant Death
15 Completed
Has Results
Study of the Impact of Parental Note Taking on the Effectiveness of Anticipatory Guidance
Conditions: Health Education;   Sudden Infant Death
Intervention: Behavioral: Note taking
16 Completed
Has Results
Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma
Condition: Asthma
Interventions: Drug: AZD3199;   Other: AZD3199 Placebo
17 Unknown  Validation of a Non Invasive Blood Marker of SIDS and Vagal Disorders
Condition: Vagal Syncope
Interventions: Biological: Blood sampling;   Other: ECG-Holter 24 h tape and sino-carotid stimulation test
18 Not yet recruiting Pilot Study of Novel Postpartum Educational Video Intervention
Conditions: Behavior;   Communication;   Language
Interventions: Other: TMW-Newborn Intervention video;   Other: Safe Sleep for your Baby (SIDS) educational video
19 Recruiting Sensory Integration (Processing) Disorder Among Children With Behavioral Insomnia and Children With Feeding Disorder
Conditions: SID;   Feeding Disorder;   SPD
20 Completed Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food
Condition: Healthy
Interventions: Drug: BI 10773/linagliptin;   Drug: BI 10773/linagliptin SID;   Drug: BI 10773/linagliptin FDC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years